P-274 Efficacy and safety of elranatamab in Japanese patients with relapsed/refractory multiple myeloma (RRMM): a pooled analysis from the MagnetisMM studies

Autor: Ishida, Tadao, Yokoyama, Hisayuki, Suzuki, Kenshi, Ito, Satoshi, Nagai, Yuya, Handa, Hiroshi, Ito, Shigeki, Kamei, Yoichi, Nakamura, Masatoshi, Viqueira, Andrea, White, Jane Liang, Take, Kazumi, Moribe, Toyoki, Iida, Shinsuke
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S186-S187
Databáze: ScienceDirect